Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain
Public ClinicalTrials.gov record NCT01001923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo-controlled Study of the Effect of a Single Injection of SAR164877 (REGN475) on Reduction of Pain From Chronic Pancreatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary objective was to demonstrate the activity of REGN475/SAR164877 in reducing the pain associated with chronic pancreatitis. Secondary objectives were: * to assess the safety and tolerability of REGN475/SAR164877 in patients with chronic pancreatitis pain; * to characterize the pharmacokinetic, pharmacodynamic, and immunogenicity profiles of REGN475/SAR164877 in this population; * to measure the change in the total daily dose of rescue medications required.
Study identification
- NCT ID
- NCT01001923
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2009 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- May 27, 2013
2009 – 2011
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sanofi-Aventis Investigational Site Number 840024 | Arcadia | California | 91007 | — |
| Sanofi-Aventis Investigational Site Number 840011 | Bell Gardens | California | 90201 | — |
| Sanofi-Aventis Investigational Site Number 840003 | Monterey | California | 93940 | — |
| Sanofi-Aventis Investigational Site Number 840048 | San Diego | California | 92103 | — |
| Sanofi-Aventis Investigational Site Number 840034 | Stanford | California | 94305 | — |
| Sanofi-Aventis Investigational Site Number 840031 | Miami | Florida | 33144 | — |
| Sanofi-Aventis Investigational Site Number 840029 | St. Petersburg | Florida | 33703 | — |
| Sanofi-Aventis Investigational Site Number 840017 | Marietta | Georgia | 30060 | — |
| Sanofi-Aventis Investigational Site Number 840013 | Worcester | Massachusetts | 01655 | — |
| Sanofi-Aventis Investigational Site Number 840030 | Lebanon | New Hampshire | 03756 | — |
| Sanofi-Aventis Investigational Site Number 840023 | New York | New York | 10016 | — |
| Sanofi-Aventis Investigational Site Number 840052 | Winston-Salem | North Carolina | 27103 | — |
| Sanofi-Aventis Investigational Site Number 840005 | Cleveland | Ohio | 44195 | — |
| Sanofi-Aventis Investigational Site Number 840043 | Dallas | Texas | 75204 | — |
| Sanofi-Aventis Investigational Site Number 840053 | DeSoto | Texas | 75115 | — |
| Sanofi-Aventis Investigational Site Number 840050 | Southlake | Texas | 76092 | — |
| Sanofi-Aventis Investigational Site Number 840040 | East Sandy | Utah | 84094 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01001923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01001923 live on ClinicalTrials.gov.